- Home
- MX vs CADL Comparison
MX vs CADL Comparison
Compare MX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MX
- CADL
- Stock Information
- Founded
- MX 2003
- CADL 1999
- Country
- MX South Korea
- CADL United States
- Employees
- MX N/A
- CADL N/A
- Industry
- MX Semiconductors
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- MX Technology
- CADL Health Care
- Exchange
- MX Nasdaq
- CADL Nasdaq
- Market Cap
- MX 144.0M
- CADL 159.1M
- IPO Year
- MX N/A
- CADL 2021
- Fundamental
- Price
- MX $4.15
- CADL $8.87
- Analyst Decision
- MX Strong Buy
- CADL Strong Buy
- Analyst Count
- MX 2
- CADL 1
- Target Price
- MX $7.50
- CADL $19.00
- AVG Volume (30 Days)
- MX 237.7K
- CADL 9.8M
- Earning Date
- MX 01-29-2025
- CADL 11-14-2024
- Dividend Yield
- MX N/A
- CADL N/A
- EPS Growth
- MX N/A
- CADL N/A
- EPS
- MX N/A
- CADL N/A
- Revenue
- MX $219,520,000.00
- CADL N/A
- Revenue This Year
- MX $3.09
- CADL N/A
- Revenue Next Year
- MX $10.06
- CADL N/A
- P/E Ratio
- MX N/A
- CADL N/A
- Revenue Growth
- MX N/A
- CADL N/A
- 52 Week Low
- MX $3.56
- CADL $1.16
- 52 Week High
- MX $8.16
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- MX 53.31
- CADL 60.78
- Support Level
- MX $3.73
- CADL $7.90
- Resistance Level
- MX $3.95
- CADL $10.38
- Average True Range (ATR)
- MX 0.15
- CADL 1.85
- MACD
- MX 0.01
- CADL 0.25
- Stochastic Oscillator
- MX 69.17
- CADL 43.71
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.